Saurabh Saha - Net Worth and Insider Trading
Saurabh Saha Net Worth
The estimated net worth of Saurabh Saha is at least $10 Million dollars as of 2024-12-25. Saurabh Saha is the CEO of Centessa Pharmaceuticals PLC and owns about 558,661 shares of Centessa Pharmaceuticals PLC (CNTA) stock worth over $9 Million. Saurabh Saha is also the Director of Clarivate PLC and owns about 23,741 shares of Clarivate PLC (CLVT) stock worth over $118,468. Details can be seen in Saurabh Saha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Saurabh Saha has not made any transactions after 2024-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Saurabh Saha
Saurabh Saha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Saurabh Saha owns 2 companies in total, including Centessa Pharmaceuticals PLC (CNTA) , and Clarivate PLC (CLVT) .
Click here to see the complete history of Saurabh Saha’s form 4 insider trades.
Insider Ownership Summary of Saurabh Saha
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2024-12-20 | director & Chief Executive Officer |
| CLVT | Clarivate PLC | 2024-08-30 | director |
Saurabh Saha Latest Holdings Summary
Saurabh Saha currently owns a total of 2 stocks. Among these stocks, Saurabh Saha owns 558,661 shares of Centessa Pharmaceuticals PLC (CNTA) as of December 20, 2024, with a value of $9 Million and a weighting of 98.76%. Saurabh Saha also owns 23,741 shares of Clarivate PLC (CLVT) as of August 30, 2024, with a value of $118,468 and a weighting of 1.24%.
Latest Holdings of Saurabh Saha
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2024-12-20 | 558,661 | 16.90 | 9,441,371 |
| CLVT | Clarivate PLC | 2024-08-30 | 23,741 | 4.99 | 118,468 |
Holding Weightings of Saurabh Saha
Saurabh Saha Form 4 Trading Tracker
According to the SEC Form 4 filings, Saurabh Saha has made a total of 13 transactions in Centessa Pharmaceuticals PLC (CNTA) over the past 5 years, including 3 buys and 10 sells. The most-recent trade in Centessa Pharmaceuticals PLC is the sale of 55,000 shares on December 20, 2024, which brought Saurabh Saha around $959,200.
According to the SEC Form 4 filings, Saurabh Saha has made a total of 1 transactions in Clarivate PLC (CLVT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Clarivate PLC is the sale of 17,646 shares on August 30, 2024, which brought Saurabh Saha around $119,110.
Insider Trading History of Saurabh Saha
- 1
Saurabh Saha Trading Performance
GuruFocus tracks the stock performance after each of Saurabh Saha's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Saurabh Saha is -12.08%. GuruFocus also compares Saurabh Saha's trading performance to market benchmark return within the same time period. The performance of stocks bought by Saurabh Saha within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Saurabh Saha's insider trading performs compared to the benchmark.
Performance of Saurabh Saha
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.42 | | | | | |
| Relative Return to S&P 500(%) | -6.15 | | | | | |
Saurabh Saha Ownership Network
Saurabh Saha Owned Company Details
What does Centessa Pharmaceuticals PLC do?
Who are the key executives at Centessa Pharmaceuticals PLC?
Saurabh Saha is the director & Chief Executive Officer of Centessa Pharmaceuticals PLC. Other key executives at Centessa Pharmaceuticals PLC include Chief People Officer Karen M. Anderson , Chief Quality Officer Tia L Bush , and General Counsel Iqbal J Hussain .
Centessa Pharmaceuticals PLC (CNTA) Insider Trades Summary
Over the past 18 months, Saurabh Saha made 10 insider transaction in Centessa Pharmaceuticals PLC (CNTA) with a net sale of 575,000. Other recent insider transactions involving Centessa Pharmaceuticals PLC (CNTA) include a net sale of 123,361 shares made by Gregory M Weinhoff , a net sale of 67,660 shares made by Karen M. Anderson , and a net sale of 41,751 shares made by Harris Rotman .
In summary, during the past 3 months, insiders sold 433,371 shares of Centessa Pharmaceuticals PLC (CNTA) in total and bought 0 shares, with a net sale of 433,371 shares. During the past 18 months, 912,901 shares of Centessa Pharmaceuticals PLC (CNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 912,901 shares.
Centessa Pharmaceuticals PLC (CNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Centessa Pharmaceuticals PLC Insider Transactions
Saurabh Saha Mailing Address
Above is the net worth, insider trading, and ownership report for Saurabh Saha. You might contact Saurabh Saha via mailing address: C/o Centessa Pharmaceuticals Plc, 3rd Floor, 1 Ashley Road, Altrincham, Cheshire X0 Wa14 2dt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
